Concepedia

Tobias M Maile

TM

Statistics

Publications

7

Citations

913

H-Index

7

Active since

2004

Affiliations

Constellation Pharmaceuticals (United States)(Current)

PDL BioPharma (United States)

The Honourable Society of Lincoln's Inn

Cancer Research UK

Tobias M Maile is an author at Constellation Pharmaceuticals (United States) specializing in life sciences, molecular biology, and genetics.

ORCID

Publications per year

2004–2016

7

Publications

7

An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells

Maia Vinogradova, Victor Gehling, Amy Gustafson et al. · Nature Chemical Biology · 2016 · 357 citations · Full text

, , +14

An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition

Brian Egan, Chih-Chi Yuan, Madeleine Craske et al. · PLoS ONE · 2016 · 167 citations · Full text

, , +17

Mass Spectrometric Quantification of Histone Post-translational Modifications by a Hybrid Chemical Labeling Method

Tobias M Maile, Anita Izrael-Tomasevic, Tommy K. Cheung et al. · Molecular & Cellular Proteomics · 2015 · 124 citations · Full text

, , +17

Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila

Michael C. Wehr, Maxine V. Holder, Ieva Gailite et al. · Nature Cell Biology · 2012 · 107 citations · Full text

, , +10

TAF1 Activates Transcription by Phosphorylation of Serine 33 in Histone H2B

Tobias M Maile, Simona Kwoczynski, Rebeccah J. Katzenberger et al. · Science · 2004 · 69 citations

, , +16

1–5 of 7